RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post...
Read moreRadiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post...
Read moreCryptocurrency investors have experienced a real rollercoaster in the last few years — the likes of Bitcoin, Ethereum and Ripple...
Read moreMetro Mining (MMI:AU) has announced Operational Update Download the PDF here. This post appeared first on investingnews.com
Read moreByron Allen is putting his broadcast TV stations up for sale. Allen Media Group said on Monday it has retained...
Read moreUber said Monday that Pierre-Dimitri Gore-Coty, one of the company’s longest-tenured top executives and the head of is delivery business...
Read moreElon Musk’s brain tech startup Neuralink has closed a $650 million funding round, the company announced Monday. ARK Invest, Founders...
Read moreSnacktime is nigh at the Golden Arches. On June 3, McDonald’s announced exactly when the Snack Wrap will return to...
Read moreTesla’s long-awaited entry into the robotaxi market — expected later this month — is coming to Austin, Texas, which has...
Read moreShares of Dollar General jumped nearly 16% on Tuesday after the discounter raised its outlook, saying it drew more middle-...
Read morePeloton on Tuesday launched its own marketplace for reselling used equipment and gear as the company looks to capitalize on...
Read moreDisclaimer: financemasterynews.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.